Johnson & Johnson asks the FDA to allow extra shots of its COVID-19 vaccine as the U.S. government moves toward expanding its booster campaign to millions more vaccinated Americans.
Andrew Jansen/News-Leader via USA Today
Last month, the FDA authorized booster shots of Pfizer’s vaccine for older Americans and other groups with heightened vulnerability to COVID-19. It’s part of a sweeping effort by the Biden administration to shore up protection amid the delta variant and potential waning vaccine immunity. J&J previously released data suggesting its vaccine remains highly effective against COVID-19 at least five months after vaccination, demonstrating 81% effectiveness against hospitalizations in the U.S.
The timing of the J&J filing was unusual given that the FDA had already scheduled its meeting on the company's data. Companies normally submit their requests well in advance of meeting announcements. A J&J executive said the company has been working with FDA on the review.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Johnson & Johnson asks FDA to authorize Covid-19 vaccine booster shotsJohnson & Johnson has asked the FDA to authorize booster shots for its coronavirus vaccine, but has left it up to the FDA and the US Centers for Disease Control and Prevention to decide just who should get their boosters and when.
Baca lebih lajut »
Johnson & Johnson Seeks U.S. Clearance For COVID-19 Vaccine Booster DosesJ&J said it filed a request with the FDA to authorize boosters for people 18 and older who previously received the company's one-shot vaccine.
Baca lebih lajut »
Johnson & Johnson seeks FDA authorization of Covid booster shotJ&J said Monday that giving a second dose two months after the first increased protection against symptomatic moderate to severe Covid-19 to 94 percent, with 100 percent protection against severe illness.
Baca lebih lajut »
Johnson & Johnson files for authorization of Covid vaccine boosterThe vaccine maker said an additional second shot of its vaccine given about two months after the first increased its effectiveness to 94 percent, compared with 70 percent protection with the single dose.
Baca lebih lajut »
Covid-19 Booster Shots Win Broad Backing From European RegulatorEurope’s top health regulator issued a broad endorsement of Covid-19 vaccine booster shots, diverging from U.S. officials’ more limited recommendation
Baca lebih lajut »